James Brian Windsor - President and CEO at Rein Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO
Issuer Symbol
RNTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Brian Windsor since 11 Mar 2025

Holdings reported by James Brian Windsor for Rein Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,122 $16,025 $2.25 05 Dec 2024 Direct
Common Stock 161 $362 $2.25 05 Dec 2024 By son
Stock Option (right to buy) 517,500 02 Dec 2024 Direct Common Stock
Series X Non-Voting Convertible Preferred 0 05 Mar 2024 Direct Common Stock

Transactions reported by James Brian Windsor for Rein Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.